A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome
The Journal of Immunology · 2025
DOI: 10.1093/jimmun/vkaf006 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Rehan Khan und 25 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Research Institute, Rutgers New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, NJ, United States. Hauptthemen laut MEDLINE: COVID-19, Systemic Inflammatory Response Syndrome, SARS-CoV-2, Toll-Like Receptors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Dysregulated innate immune responses contribute to multisystem inflammatory syndrome in children (MIS-C), characterized by gastrointestinal, mucocutaneous, and/or cardiovascular injury occurring weeks after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure. To investigate innate immune functions, we stimulated ex vivo peripheral blood cells from MIS-C patients with agonists of Toll-like receptors (TLR), key innate immune response initiators. We found severely dampened cytokine responses and elevated gene expression of negative regulators of TLR signaling. Increased plasma levels of zonulin, a gut leakage marker, were also detected. These effects were also observed in fully convalescent children months after MIS-C recovery. When we investigated the genetic background of patients in relation to TLR responsiveness, we found that cells from MIS-C children carrying rare heterozygous variants of lysosomal trafficking regulator (LYST) were less refractory to TLR stimulation and exhibited lysosomal and mitochondrial abnormalities with altered energy metabolism. Moreover, these rare LYST variant heterozygous carriers tended to exhibit unfavorable clinical laboratory indicators of inflammation, including more profound lymphopenia. The results of our observational study have several implications. First, TLR hyporesponsiveness may be associated with hyperinflammation and/or excessive or prolonged stimulation with gut-originated TLR ligands. Second, TLR hyporesponsiveness during MIS-C may be protective, since LYST variant heterozygous carriers exhibited reduced TLR hyporesponsiveness and unfavorable clinical laboratory indicators of inflammation. Thus, links may exist between genetic background, ability to establish a refractory immune state, and MIS-C clinical spectrum. Third, the possibility exists that prolonged TLR hyporesponsiveness is one of the mechanisms driving long coronavirus disease (COVID), which highlights the need to monitor long-term consequences of MIS-C.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Public Health Research Institute, Rutgers New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, NJ, United States.
- Pediatric Genomics Discovery Program, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, United States.
- Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, United States.
- Pediatric Clinical Research Center, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States.
- Department of Pediatrics, Clinical Research Center, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States.
- Department of Pediatrics, Cooperman Barnabas Medical Center, Livingston, NJ, United States.
ORCID-Profile: Rehan Khan, Tracy Andrews, Sunanda Gaur, Aalok R Singh, Hulya Bukulmez, David Kaelber, Yukiko Kimura, Usha Ganapathi, Rahul Ukey, John K Kuster, Myriam Casseus, Jane C Burns, Lawrence C Kleinman, Daniel B Horton, Maria Laura Gennaro
Förderung
- NCATS NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of Child Health and Human Development
- NICHD NIH HHS
- NIAID NIH HHS
- National Center for Advancing Translational Sciences
Zitieren
APA
Khan, R., Ji, W., Guzman Rivera, J., Madhvi, A., Andrews, T., Richlin, B., Suarez, C., Gaur, S., Hasan, U. N., Cuddy, W., Singh, A. R., Bukulmez, H., Kaelber, D., Kimura, Y., Ganapathi, U., Michailidis, I. E., Ukey, R., Moroso-Fela, S., Kuster, J. K., …, & Gennaro, M. L. (2025). A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf006
Vancouver
Khan R, Ji W, Guzman Rivera J, Madhvi A, Andrews T, Richlin B, et al. A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf006
BibTeX
@article{Khan2025,
author = {Khan, Rehan and Ji, Weizhen and Guzman Rivera, Jeisac and Madhvi, Abhilasha and Andrews, Tracy and Richlin, Benjamin and Suarez, Christian and Gaur, Sunanda and Hasan, Uzma N and Cuddy, William and Singh, Aalok R and Bukulmez, Hulya and Kaelber, David and Kimura, Yukiko and Ganapathi, Usha and Michailidis, Ioannis E and Ukey, Rahul and Moroso-Fela, Sandra and Kuster, John K and Casseus, Myriam and Roy, Jason and Burns, Jane C and Kleinman, Lawrence C and Horton, Daniel B and Lakhani, Saquib A and Gennaro, Maria Laura},
title = {A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome},
journal = {The Journal of Immunology},
year = {2025},
doi = {10.1093/jimmun/vkaf006}
}
EUVIMED